Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Carroll

Showing results (421-430 of 573) with videos related to

Pageof 58
Sort By:
Vaccine|September 17, 2019
UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developmentsRob J Noad, Karl Simpson, Anthony R Fooks, et al.
Scientific Reports|September 2, 2020
Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodiesKimberley Steeds, Yper Hall, Gillian S Slack, et al.
Archives of Otolaryngology--Head & Neck Surgery|August 4, 2001
Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neckL L Gleich, J L Gluckman, J Nemunaitis, et al.
Genome Biology|September 7, 2020
Variation around the dominant viral genome sequence contributes to viral load and outcome in patients with Ebola virus diseaseXiaofeng Dong, Jordana Munoz-Basagoiti, Natasha Y Rickett, et al.
The Journal of Infectious Diseases|December 11, 2021
Sequential Delivery of Live Attenuated Influenza Vaccine and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Ferret Model Can Reduce SARS-CoV-2 Shedding and Does Not Result in Enhanced Lung PathologyKathryn A Ryan, Katarzyna E Schewe, Jonathan Crowe, et al.
Frontiers in Immunology|September 26, 2022
mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individualsStephanie Longet, Alexander Hargreaves, Saoirse Healy, et al.
Nature Communications|February 20, 2021
Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013-16 West Africa epidemicT R W Tipton, Y Hall, J A Bore, et al.
Genome Biology|November 23, 2014
Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicityStuart D Dowall, David A Matthews, Isabel Garcia-Dorival, et al.
Molecular Microbiology|June 27, 2019
The Lyme disease spirochete's BpuR DNA/RNA-binding protein is differentially expressed during the mammal-tick infectious cycle, which affects translation of the SodA superoxide dismutaseBrandon L Jutras, Christina R Savage, William K Arnold, et al.
Cell|May 20, 2009
Protein architecture of the human kinetochore microtubule attachment siteXiaohu Wan, Ryan P O'Quinn, Heather L Pierce, et al.
Pageof 58

Showing results (421-430 of 573) with videos related to

Sort By:
Pageof 58
Vaccine|September 17, 2019
UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developmentsRob J Noad, Karl Simpson, Anthony R Fooks, et al.
Scientific Reports|September 2, 2020
Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodiesKimberley Steeds, Yper Hall, Gillian S Slack, et al.
Archives of Otolaryngology--Head & Neck Surgery|August 4, 2001
Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neckL L Gleich, J L Gluckman, J Nemunaitis, et al.
Genome Biology|September 7, 2020
Variation around the dominant viral genome sequence contributes to viral load and outcome in patients with Ebola virus diseaseXiaofeng Dong, Jordana Munoz-Basagoiti, Natasha Y Rickett, et al.
The Journal of Infectious Diseases|December 11, 2021
Sequential Delivery of Live Attenuated Influenza Vaccine and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Ferret Model Can Reduce SARS-CoV-2 Shedding and Does Not Result in Enhanced Lung PathologyKathryn A Ryan, Katarzyna E Schewe, Jonathan Crowe, et al.
Frontiers in Immunology|September 26, 2022
mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individualsStephanie Longet, Alexander Hargreaves, Saoirse Healy, et al.
Nature Communications|February 20, 2021
Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013-16 West Africa epidemicT R W Tipton, Y Hall, J A Bore, et al.
Genome Biology|November 23, 2014
Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicityStuart D Dowall, David A Matthews, Isabel Garcia-Dorival, et al.
Molecular Microbiology|June 27, 2019
The Lyme disease spirochete's BpuR DNA/RNA-binding protein is differentially expressed during the mammal-tick infectious cycle, which affects translation of the SodA superoxide dismutaseBrandon L Jutras, Christina R Savage, William K Arnold, et al.
Cell|May 20, 2009
Protein architecture of the human kinetochore microtubule attachment siteXiaohu Wan, Ryan P O'Quinn, Heather L Pierce, et al.
Pageof 58